Adult Vaccines Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Preventive Vaccine, Therapeutic Vaccine); Disease (Influenza, Meningococcal, Zoster Shingles, Pneumococcal,Diphtheria, Tetanus, Pertussis (DTP), Hepatitis, Measles, Mumps, Rubella and Varicella (MMRV)); Technology (Non-Live Attenuated Vaccines, Inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines) and Geography
Report Code: TIPRE00007244 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Vaccines are products that guard people against dangerous and potentially life-threatening diseases. Most vaccines are given by injection, but some are given orally or nasally. All adults need seasonal flu (influenza) vaccine every year. The flu vaccine is very crucial for people with chronic health conditions, pregnant women, and older adults.
MARKET DYNAMICS
The adult vaccines market is anticipated to grow in the forecast, owing to rising prevalence of infectious diseases in the adult population with rising awareness among the population regarding the advantages of vaccination. In addition, increasing investment in R&D by governmental bodies for the development of novel drugs and vaccine is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Adult Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in adult vaccines market with detailed market segmentation by type, by disease, by technology and geography. The in adult vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in adult vaccines market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The in adult vaccines market is segmented on the basis of type, by disease and technology. Based on type the market is segmented as preventive vaccine and therapeutic vaccine. On the basis of disease the market is categorized as influenza, meningococcal, zoster shingles, pneumococcal, diphtheria, tetanus, pertussis (DTP) and hepatitis, measles, mumps, rubella and varicella (MMRV). Also, based on technology, the market is segmented as, non-live attenuated vaccines, inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines and Conjugate Vaccines.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in Adult Vaccines Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The adult vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting adult vaccines market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the adult vaccines market in these regions.
The report covers key developments in the in Adult Vaccines Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in Adult Vaccines Market are anticipated to have lucrative growth opportunities in the future with the rising demand for in Adult Vaccines Market in the global market. Below mentioned is the list of few companies engaged in the in vivo CRO market.
The report also includes the profiles of key in Adult Vaccines Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Vaccines are products that guard people against dangerous and potentially life-threatening diseases. Most vaccines are given by injection, but some are given orally or nasally. All adults need seasonal flu (influenza) vaccine every year. The flu vaccine is very crucial for people with chronic health conditions, pregnant women, and older adults.
MARKET DYNAMICS
The adult vaccines market is anticipated to grow in the forecast, owing to rising prevalence of infectious diseases in the adult population with rising awareness among the population regarding the advantages of vaccination. In addition, increasing investment in R&D by governmental bodies for the development of novel drugs and vaccine is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Adult Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in adult vaccines market with detailed market segmentation by type, by disease, by technology and geography. The in adult vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in adult vaccines market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The in adult vaccines market is segmented on the basis of type, by disease and technology. Based on type the market is segmented as preventive vaccine and therapeutic vaccine. On the basis of disease the market is categorized as influenza, meningococcal, zoster shingles, pneumococcal, diphtheria, tetanus, pertussis (DTP) and hepatitis, measles, mumps, rubella and varicella (MMRV). Also, based on technology, the market is segmented as, non-live attenuated vaccines, inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines and Conjugate Vaccines.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in Adult Vaccines Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The adult vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting adult vaccines market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the adult vaccines market in these regions.
The report covers key developments in the in Adult Vaccines Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in Adult Vaccines Market are anticipated to have lucrative growth opportunities in the future with the rising demand for in Adult Vaccines Market in the global market. Below mentioned is the list of few companies engaged in the in vivo CRO market.
The report also includes the profiles of key in Adult Vaccines Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AstraZeneca
- Bharat Biotech
- Dynavax Technologies Corporation
- GlaxoSmithKline
- Johnson & Johnson
- Merck and Co
- Novartis
- Pfizer
- Sanofi Pasteur
- Serum Institute of India
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Adult Vaccines Market - By Type
1.3.2 Adult Vaccines Market - By Disease
1.3.3 Adult Vaccines Market - By Technology
1.3.4 Adult Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ADULT VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ADULT VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ADULT VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. ADULT VACCINES - GLOBAL MARKET OVERVIEW
6.2. ADULT VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ADULT VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PREVENTIVE VACCINE
7.3.1. Overview
7.3.2. Preventive Vaccine Market Forecast and Analysis
7.4. THERAPEUTIC VACCINE
7.4.1. Overview
7.4.2. Therapeutic Vaccine Market Forecast and Analysis
8. ADULT VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE
8.1. OVERVIEW
8.2. DISEASE MARKET FORECASTS AND ANALYSIS
8.3. INFLUENZA
8.3.1. Overview
8.3.2. Influenza Market Forecast and Analysis
8.4. MENINGOCOCCAL
8.4.1. Overview
8.4.2. Meningococcal Market Forecast and Analysis
8.5. ZOSTER SHINGLES
8.5.1. Overview
8.5.2. Zoster Shingles Market Forecast and Analysis
8.6. PNEUMOCOCCAL,DIPHTHERIA, TETANUS, PERTUSSIS (DTP)
8.6.1. Overview
8.6.2. Pneumococcal,Diphtheria, Tetanus, Pertussis (DTP) Market Forecast and Analysis
8.7. HEPATITIS, MEASLES, MUMPS, RUBELLA AND VARICELLA (MMRV)
8.7.1. Overview
8.7.2. Hepatitis, Measles, Mumps, Rubella and Varicella (MMRV) Market Forecast and Analysis
9. ADULT VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. NON-LIVE ATTENUATED VACCINES
9.3.1. Overview
9.3.2. Non-Live Attenuated Vaccines Market Forecast and Analysis
9.4. INACTIVATED VIRAL/BACTERIAL VACCINES
9.4.1. Overview
9.4.2. Inactivated Viral/Bacterial Vaccines Market Forecast and Analysis
9.5. TOXOID VACCINES
9.5.1. Overview
9.5.2. Toxoid Vaccines Market Forecast and Analysis
9.6. RECOMBINANT VACCINES
9.6.1. Overview
9.6.2. Recombinant Vaccines Market Forecast and Analysis
9.7. CONJUGATE VACCINES
9.7.1. Overview
9.7.2. Conjugate Vaccines Market Forecast and Analysis
10. ADULT VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Adult Vaccines Market Overview
10.1.2 North America Adult Vaccines Market Forecasts and Analysis
10.1.3 North America Adult Vaccines Market Forecasts and Analysis - By Type
10.1.4 North America Adult Vaccines Market Forecasts and Analysis - By Disease
10.1.5 North America Adult Vaccines Market Forecasts and Analysis - By Technology
10.1.6 North America Adult Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Adult Vaccines Market
10.1.6.1.1 United States Adult Vaccines Market by Type
10.1.6.1.2 United States Adult Vaccines Market by Disease
10.1.6.1.3 United States Adult Vaccines Market by Technology
10.1.6.2 Canada Adult Vaccines Market
10.1.6.2.1 Canada Adult Vaccines Market by Type
10.1.6.2.2 Canada Adult Vaccines Market by Disease
10.1.6.2.3 Canada Adult Vaccines Market by Technology
10.1.6.3 Mexico Adult Vaccines Market
10.1.6.3.1 Mexico Adult Vaccines Market by Type
10.1.6.3.2 Mexico Adult Vaccines Market by Disease
10.1.6.3.3 Mexico Adult Vaccines Market by Technology
10.2. EUROPE
10.2.1 Europe Adult Vaccines Market Overview
10.2.2 Europe Adult Vaccines Market Forecasts and Analysis
10.2.3 Europe Adult Vaccines Market Forecasts and Analysis - By Type
10.2.4 Europe Adult Vaccines Market Forecasts and Analysis - By Disease
10.2.5 Europe Adult Vaccines Market Forecasts and Analysis - By Technology
10.2.6 Europe Adult Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Adult Vaccines Market
10.2.6.1.1 Germany Adult Vaccines Market by Type
10.2.6.1.2 Germany Adult Vaccines Market by Disease
10.2.6.1.3 Germany Adult Vaccines Market by Technology
10.2.6.2 France Adult Vaccines Market
10.2.6.2.1 France Adult Vaccines Market by Type
10.2.6.2.2 France Adult Vaccines Market by Disease
10.2.6.2.3 France Adult Vaccines Market by Technology
10.2.6.3 Italy Adult Vaccines Market
10.2.6.3.1 Italy Adult Vaccines Market by Type
10.2.6.3.2 Italy Adult Vaccines Market by Disease
10.2.6.3.3 Italy Adult Vaccines Market by Technology
10.2.6.4 Spain Adult Vaccines Market
10.2.6.4.1 Spain Adult Vaccines Market by Type
10.2.6.4.2 Spain Adult Vaccines Market by Disease
10.2.6.4.3 Spain Adult Vaccines Market by Technology
10.2.6.5 United Kingdom Adult Vaccines Market
10.2.6.5.1 United Kingdom Adult Vaccines Market by Type
10.2.6.5.2 United Kingdom Adult Vaccines Market by Disease
10.2.6.5.3 United Kingdom Adult Vaccines Market by Technology
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Adult Vaccines Market Overview
10.3.2 Asia-Pacific Adult Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Adult Vaccines Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Adult Vaccines Market Forecasts and Analysis - By Disease
10.3.5 Asia-Pacific Adult Vaccines Market Forecasts and Analysis - By Technology
10.3.6 Asia-Pacific Adult Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Adult Vaccines Market
10.3.6.1.1 Australia Adult Vaccines Market by Type
10.3.6.1.2 Australia Adult Vaccines Market by Disease
10.3.6.1.3 Australia Adult Vaccines Market by Technology
10.3.6.2 China Adult Vaccines Market
10.3.6.2.1 China Adult Vaccines Market by Type
10.3.6.2.2 China Adult Vaccines Market by Disease
10.3.6.2.3 China Adult Vaccines Market by Technology
10.3.6.3 India Adult Vaccines Market
10.3.6.3.1 India Adult Vaccines Market by Type
10.3.6.3.2 India Adult Vaccines Market by Disease
10.3.6.3.3 India Adult Vaccines Market by Technology
10.3.6.4 Japan Adult Vaccines Market
10.3.6.4.1 Japan Adult Vaccines Market by Type
10.3.6.4.2 Japan Adult Vaccines Market by Disease
10.3.6.4.3 Japan Adult Vaccines Market by Technology
10.3.6.5 South Korea Adult Vaccines Market
10.3.6.5.1 South Korea Adult Vaccines Market by Type
10.3.6.5.2 South Korea Adult Vaccines Market by Disease
10.3.6.5.3 South Korea Adult Vaccines Market by Technology
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Adult Vaccines Market Overview
10.4.2 Middle East and Africa Adult Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Adult Vaccines Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Adult Vaccines Market Forecasts and Analysis - By Disease
10.4.5 Middle East and Africa Adult Vaccines Market Forecasts and Analysis - By Technology
10.4.6 Middle East and Africa Adult Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Adult Vaccines Market
10.4.6.1.1 South Africa Adult Vaccines Market by Type
10.4.6.1.2 South Africa Adult Vaccines Market by Disease
10.4.6.1.3 South Africa Adult Vaccines Market by Technology
10.4.6.2 Saudi Arabia Adult Vaccines Market
10.4.6.2.1 Saudi Arabia Adult Vaccines Market by Type
10.4.6.2.2 Saudi Arabia Adult Vaccines Market by Disease
10.4.6.2.3 Saudi Arabia Adult Vaccines Market by Technology
10.4.6.3 U.A.E Adult Vaccines Market
10.4.6.3.1 U.A.E Adult Vaccines Market by Type
10.4.6.3.2 U.A.E Adult Vaccines Market by Disease
10.4.6.3.3 U.A.E Adult Vaccines Market by Technology
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Adult Vaccines Market Overview
10.5.2 South and Central America Adult Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Adult Vaccines Market Forecasts and Analysis - By Type
10.5.4 South and Central America Adult Vaccines Market Forecasts and Analysis - By Disease
10.5.5 South and Central America Adult Vaccines Market Forecasts and Analysis - By Technology
10.5.6 South and Central America Adult Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Adult Vaccines Market
10.5.6.1.1 Brazil Adult Vaccines Market by Type
10.5.6.1.2 Brazil Adult Vaccines Market by Disease
10.5.6.1.3 Brazil Adult Vaccines Market by Technology
10.5.6.2 Argentina Adult Vaccines Market
10.5.6.2.1 Argentina Adult Vaccines Market by Type
10.5.6.2.2 Argentina Adult Vaccines Market by Disease
10.5.6.2.3 Argentina Adult Vaccines Market by Technology
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ADULT VACCINES MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BHARAT BIOTECH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. DYNAVAX TECHNOLOGIES CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JOHNSON AND JOHNSON
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI PASTEUR
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SERUM INSTITUTE OF INDIA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Adult Vaccines Market - By Type
1.3.2 Adult Vaccines Market - By Disease
1.3.3 Adult Vaccines Market - By Technology
1.3.4 Adult Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ADULT VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ADULT VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ADULT VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. ADULT VACCINES - GLOBAL MARKET OVERVIEW
6.2. ADULT VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ADULT VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PREVENTIVE VACCINE
7.3.1. Overview
7.3.2. Preventive Vaccine Market Forecast and Analysis
7.4. THERAPEUTIC VACCINE
7.4.1. Overview
7.4.2. Therapeutic Vaccine Market Forecast and Analysis
8. ADULT VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE
8.1. OVERVIEW
8.2. DISEASE MARKET FORECASTS AND ANALYSIS
8.3. INFLUENZA
8.3.1. Overview
8.3.2. Influenza Market Forecast and Analysis
8.4. MENINGOCOCCAL
8.4.1. Overview
8.4.2. Meningococcal Market Forecast and Analysis
8.5. ZOSTER SHINGLES
8.5.1. Overview
8.5.2. Zoster Shingles Market Forecast and Analysis
8.6. PNEUMOCOCCAL,DIPHTHERIA, TETANUS, PERTUSSIS (DTP)
8.6.1. Overview
8.6.2. Pneumococcal,Diphtheria, Tetanus, Pertussis (DTP) Market Forecast and Analysis
8.7. HEPATITIS, MEASLES, MUMPS, RUBELLA AND VARICELLA (MMRV)
8.7.1. Overview
8.7.2. Hepatitis, Measles, Mumps, Rubella and Varicella (MMRV) Market Forecast and Analysis
9. ADULT VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. NON-LIVE ATTENUATED VACCINES
9.3.1. Overview
9.3.2. Non-Live Attenuated Vaccines Market Forecast and Analysis
9.4. INACTIVATED VIRAL/BACTERIAL VACCINES
9.4.1. Overview
9.4.2. Inactivated Viral/Bacterial Vaccines Market Forecast and Analysis
9.5. TOXOID VACCINES
9.5.1. Overview
9.5.2. Toxoid Vaccines Market Forecast and Analysis
9.6. RECOMBINANT VACCINES
9.6.1. Overview
9.6.2. Recombinant Vaccines Market Forecast and Analysis
9.7. CONJUGATE VACCINES
9.7.1. Overview
9.7.2. Conjugate Vaccines Market Forecast and Analysis
10. ADULT VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Adult Vaccines Market Overview
10.1.2 North America Adult Vaccines Market Forecasts and Analysis
10.1.3 North America Adult Vaccines Market Forecasts and Analysis - By Type
10.1.4 North America Adult Vaccines Market Forecasts and Analysis - By Disease
10.1.5 North America Adult Vaccines Market Forecasts and Analysis - By Technology
10.1.6 North America Adult Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Adult Vaccines Market
10.1.6.1.1 United States Adult Vaccines Market by Type
10.1.6.1.2 United States Adult Vaccines Market by Disease
10.1.6.1.3 United States Adult Vaccines Market by Technology
10.1.6.2 Canada Adult Vaccines Market
10.1.6.2.1 Canada Adult Vaccines Market by Type
10.1.6.2.2 Canada Adult Vaccines Market by Disease
10.1.6.2.3 Canada Adult Vaccines Market by Technology
10.1.6.3 Mexico Adult Vaccines Market
10.1.6.3.1 Mexico Adult Vaccines Market by Type
10.1.6.3.2 Mexico Adult Vaccines Market by Disease
10.1.6.3.3 Mexico Adult Vaccines Market by Technology
10.2. EUROPE
10.2.1 Europe Adult Vaccines Market Overview
10.2.2 Europe Adult Vaccines Market Forecasts and Analysis
10.2.3 Europe Adult Vaccines Market Forecasts and Analysis - By Type
10.2.4 Europe Adult Vaccines Market Forecasts and Analysis - By Disease
10.2.5 Europe Adult Vaccines Market Forecasts and Analysis - By Technology
10.2.6 Europe Adult Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Adult Vaccines Market
10.2.6.1.1 Germany Adult Vaccines Market by Type
10.2.6.1.2 Germany Adult Vaccines Market by Disease
10.2.6.1.3 Germany Adult Vaccines Market by Technology
10.2.6.2 France Adult Vaccines Market
10.2.6.2.1 France Adult Vaccines Market by Type
10.2.6.2.2 France Adult Vaccines Market by Disease
10.2.6.2.3 France Adult Vaccines Market by Technology
10.2.6.3 Italy Adult Vaccines Market
10.2.6.3.1 Italy Adult Vaccines Market by Type
10.2.6.3.2 Italy Adult Vaccines Market by Disease
10.2.6.3.3 Italy Adult Vaccines Market by Technology
10.2.6.4 Spain Adult Vaccines Market
10.2.6.4.1 Spain Adult Vaccines Market by Type
10.2.6.4.2 Spain Adult Vaccines Market by Disease
10.2.6.4.3 Spain Adult Vaccines Market by Technology
10.2.6.5 United Kingdom Adult Vaccines Market
10.2.6.5.1 United Kingdom Adult Vaccines Market by Type
10.2.6.5.2 United Kingdom Adult Vaccines Market by Disease
10.2.6.5.3 United Kingdom Adult Vaccines Market by Technology
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Adult Vaccines Market Overview
10.3.2 Asia-Pacific Adult Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Adult Vaccines Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Adult Vaccines Market Forecasts and Analysis - By Disease
10.3.5 Asia-Pacific Adult Vaccines Market Forecasts and Analysis - By Technology
10.3.6 Asia-Pacific Adult Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Adult Vaccines Market
10.3.6.1.1 Australia Adult Vaccines Market by Type
10.3.6.1.2 Australia Adult Vaccines Market by Disease
10.3.6.1.3 Australia Adult Vaccines Market by Technology
10.3.6.2 China Adult Vaccines Market
10.3.6.2.1 China Adult Vaccines Market by Type
10.3.6.2.2 China Adult Vaccines Market by Disease
10.3.6.2.3 China Adult Vaccines Market by Technology
10.3.6.3 India Adult Vaccines Market
10.3.6.3.1 India Adult Vaccines Market by Type
10.3.6.3.2 India Adult Vaccines Market by Disease
10.3.6.3.3 India Adult Vaccines Market by Technology
10.3.6.4 Japan Adult Vaccines Market
10.3.6.4.1 Japan Adult Vaccines Market by Type
10.3.6.4.2 Japan Adult Vaccines Market by Disease
10.3.6.4.3 Japan Adult Vaccines Market by Technology
10.3.6.5 South Korea Adult Vaccines Market
10.3.6.5.1 South Korea Adult Vaccines Market by Type
10.3.6.5.2 South Korea Adult Vaccines Market by Disease
10.3.6.5.3 South Korea Adult Vaccines Market by Technology
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Adult Vaccines Market Overview
10.4.2 Middle East and Africa Adult Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Adult Vaccines Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Adult Vaccines Market Forecasts and Analysis - By Disease
10.4.5 Middle East and Africa Adult Vaccines Market Forecasts and Analysis - By Technology
10.4.6 Middle East and Africa Adult Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Adult Vaccines Market
10.4.6.1.1 South Africa Adult Vaccines Market by Type
10.4.6.1.2 South Africa Adult Vaccines Market by Disease
10.4.6.1.3 South Africa Adult Vaccines Market by Technology
10.4.6.2 Saudi Arabia Adult Vaccines Market
10.4.6.2.1 Saudi Arabia Adult Vaccines Market by Type
10.4.6.2.2 Saudi Arabia Adult Vaccines Market by Disease
10.4.6.2.3 Saudi Arabia Adult Vaccines Market by Technology
10.4.6.3 U.A.E Adult Vaccines Market
10.4.6.3.1 U.A.E Adult Vaccines Market by Type
10.4.6.3.2 U.A.E Adult Vaccines Market by Disease
10.4.6.3.3 U.A.E Adult Vaccines Market by Technology
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Adult Vaccines Market Overview
10.5.2 South and Central America Adult Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Adult Vaccines Market Forecasts and Analysis - By Type
10.5.4 South and Central America Adult Vaccines Market Forecasts and Analysis - By Disease
10.5.5 South and Central America Adult Vaccines Market Forecasts and Analysis - By Technology
10.5.6 South and Central America Adult Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Adult Vaccines Market
10.5.6.1.1 Brazil Adult Vaccines Market by Type
10.5.6.1.2 Brazil Adult Vaccines Market by Disease
10.5.6.1.3 Brazil Adult Vaccines Market by Technology
10.5.6.2 Argentina Adult Vaccines Market
10.5.6.2.1 Argentina Adult Vaccines Market by Type
10.5.6.2.2 Argentina Adult Vaccines Market by Disease
10.5.6.2.3 Argentina Adult Vaccines Market by Technology
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ADULT VACCINES MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BHARAT BIOTECH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. DYNAVAX TECHNOLOGIES CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JOHNSON AND JOHNSON
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI PASTEUR
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SERUM INSTITUTE OF INDIA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1.AstraZeneca
2.Bharat Biotech
3.Dynavax Technologies Corporation
4.GlaxoSmithKline
5.Johnson and Johnson
6.Merck and Co
7.Novartis
8.Pfizer
9.Sanofi Pasteur
10.Serum Institute of India
1.AstraZeneca
2.Bharat Biotech
3.Dynavax Technologies Corporation
4.GlaxoSmithKline
5.Johnson and Johnson
6.Merck and Co
7.Novartis
8.Pfizer
9.Sanofi Pasteur
10.Serum Institute of India